In cervical cancer cells, sustained degradation of p53 and elevated levels of p63 enable p63 to demonstrate a capacity to regulate PTEN comparable to, or even exceeding, that of p53, depending on the level of HPV E6. The gene discussed is PTEN; the disease is cervical cancer.